✦ LIBER ✦
Bortezomib (Velcade), Rituximab, Cyclophosphamide, and Dexamethasone Combination Regimen Is Active as Front-Line Therapy of Low-Grade Non-Hodgkin Lymphoma
✍ Scribed by Chadi Nabhan; Dana Villines; Neil Dalal; Kathy Tolzien; Mark Kozolff; Alexander Starr
- Book ID
- 119218781
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 461 KB
- Volume
- 12
- Category
- Article
- ISSN
- 2152-2650
No coin nor oath required. For personal study only.